Author

D. C. Montrose

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Iavarone· 1 shared A. J. Dannenberg· 1 shared A. Lasorella· 1 shared B. Desai· 1 shared J. H. Healey· 1 shared J. Li· 1 shared J. Massague· 1 shared J. Philip· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Iavarone

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivMay 26, 2022

p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression

M. Ghosh, S. Saha, J. Li…·L. A. Martinez

This study shows p53 suppresses tumors by promoting TREX1 degradation, leading to cytosolic DNA accumulation and activation of the cGAS/STING pathway, which induces type I interferons.

DOI 10.1016/j.molcel.2022.12.023

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 6, 2020

Anti-tumor effects of an Id antagonist with no acquired resistance

P. M. Wojnarowicz, M. G. Escalono, Y.-H. Huang…·R. Benezra

This study demonstrates that AGX51, an Id antagonist, effectively inhibits tumor growth in multiple cancer models without inducing acquired resistance.

DOI 10.1101/2020.01.06.894840

mouseexperimental assay

𝕏 PostBluesky